These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 24589316)
1. Effect of cinacalcet treatment on vascular arterial stiffness among peritoneal dialysis patients with secondary hyperparathyroidism. Chow KM; Szeto CC; Kwan BC; Cheng PM; Pang WF; Leung CB; Li PK Nephrology (Carlton); 2014 Jun; 19(6):339-44. PubMed ID: 24589316 [TBL] [Abstract][Full Text] [Related]
2. Does cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism, improve arterial stiffness in patients on continuous ambulatory peritoneal dialysis? Suzuki H; Inoue T; Watanabe Y; Kikuta T; Sato T; Tsuda M; Uchida K Adv Perit Dial; 2011; 27():134-9. PubMed ID: 22073845 [TBL] [Abstract][Full Text] [Related]
3. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. Block GA; Martin KJ; de Francisco AL; Turner SA; Avram MM; Suranyi MG; Hercz G; Cunningham J; Abu-Alfa AK; Messa P; Coyne DW; Locatelli F; Cohen RM; Evenepoel P; Moe SM; Fournier A; Braun J; McCary LC; Zani VJ; Olson KA; Drüeke TB; Goodman WG N Engl J Med; 2004 Apr; 350(15):1516-25. PubMed ID: 15071126 [TBL] [Abstract][Full Text] [Related]
4. Cinacalcet may reduce arterial stiffness in patients with chronic renal disease and secondary hyperparathyroidism - results of a small-scale, prospective, observational study. Bonet J; Bayés B; Fernández-Crespo P; Casals M; López-Ayerbe J; Romero R Clin Nephrol; 2011 Mar; 75(3):181-7. PubMed ID: 21329627 [TBL] [Abstract][Full Text] [Related]
5. Cinacalcet treatment in dialysis patients with secondary hyperparathyroidism: effects and open issues. Drüeke TB Ther Apher Dial; 2008 Oct; 12 Suppl 1():S2-12. PubMed ID: 19032522 [TBL] [Abstract][Full Text] [Related]
6. Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study. Lindberg JS; Culleton B; Wong G; Borah MF; Clark RV; Shapiro WB; Roger SD; Husserl FE; Klassen PS; Guo MD; Albizem MB; Coburn JW J Am Soc Nephrol; 2005 Mar; 16(3):800-7. PubMed ID: 15689407 [TBL] [Abstract][Full Text] [Related]
7. Vascular stiffness in incident peritoneal dialysis patients over time. Tang M; Romann A; Chiarelli G; Djurdjev O; Beaulieu M; Sigrist M; Taylor P; Singh S; Levin A Clin Nephrol; 2012 Oct; 78(4):254-62. PubMed ID: 22541684 [TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis. Chonchol M; Locatelli F; Abboud HE; Charytan C; de Francisco AL; Jolly S; Kaplan M; Roger SD; Sarkar S; Albizem MB; Mix TC; Kubo Y; Block GA Am J Kidney Dis; 2009 Feb; 53(2):197-207. PubMed ID: 19110359 [TBL] [Abstract][Full Text] [Related]
9. Cinacalcet is effective in relapses of secondary hyperparathyroidism after parathyroidectomy. Lomonte C; Antonelli M; Losurdo N; Marchio G; Giammaria B; Basile C Nephrol Dial Transplant; 2007 Jul; 22(7):2056-62. PubMed ID: 17449495 [TBL] [Abstract][Full Text] [Related]
10. Effects of cinacalcet on bone mineral density in patients with secondary hyperparathyroidism. Lien YH; Silva AL; Whittman D Nephrol Dial Transplant; 2005 Jun; 20(6):1232-7. PubMed ID: 15840675 [TBL] [Abstract][Full Text] [Related]
11. Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism. Dong BJ Clin Ther; 2005 Nov; 27(11):1725-51. PubMed ID: 16368445 [TBL] [Abstract][Full Text] [Related]